| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
307,596
|
299,492
|
285,378
|
255,727
| | Cost of Revenue | 103,529 | 93,543 | 96,749 | 99,844 | | |
Gross Profit
|
204,067
|
205,949
|
188,629
|
155,883
| |
|
Operating Expenses |
|
Research Development | 51,819 | 52,432 | 46,994 | 43,340 |
|
Selling General and Administrative | 81,312 | 89,108 | 77,916 | 66,507 |
|
Non Recurring |
-
|
-
|
-
| 2,906 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
70,936
|
64,409
|
63,719
|
43,130
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 7,247 | 6,983 | 6,530 | 9,086 |
|
Earnings Before Interest And Taxes | 78,183 | 71,392 | 70,249 | 52,216 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 78,183 | 71,392 | 70,249 | 52,216 |
|
Income Tax Expense | 20,018 | 20,290 | 18,727 | 18,467 |
|
Minority Interest | (33,734) | (25,714) | (25,641) | (20,967) |
|
|
|
Net Income From Continuing Ops | 24,431 | 25,388 | 25,881 | 12,782 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
24,431
|
25,388
|
25,881
|
12,782
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
24,431
|
25,388
|
25,881
|
12,782
|
|